Cargando…
Prevention of Streptozotocin-Induced Diabetic Nephropathy by MG132: Possible Roles of Nrf2 and IκB
Our previous study showed that proteasomal inhibitor MG132 can prevent diabetic nephropathy (DN) along with upregulation of nuclear factor (erythroid-derived 2)-like 2 (Nrf2). The present study was to investigate whether MG132 can prevent DN in wild-type and Nrf2-KO mice. Type 1 diabetes was induced...
Autores principales: | Kong, Lili, Wang, Yangwei, Luo, Manyu, Tan, Yi, Cui, Wenpeng, Miao, Lining |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360973/ https://www.ncbi.nlm.nih.gov/pubmed/28373900 http://dx.doi.org/10.1155/2017/3671751 |
Ejemplares similares
-
Preventive and Therapeutic Effects of MG132 by Activating Nrf2-ARE Signaling Pathway on Oxidative Stress-Induced Cardiovascular and Renal Injury
por: Cui, Wenpeng, et al.
Publicado: (2013) -
Prevention of Diabetic Nephropathy by Sulforaphane: Possible Role of Nrf2 Upregulation and Activation
por: Cui, Wenpeng, et al.
Publicado: (2012) -
The Role of MicroRNAs in Diabetic Nephropathy
por: Wu, Hao, et al.
Publicado: (2014) -
Is rs759853 polymorphism in promoter of aldose reductase gene a risk factor for diabetic nephropathy? A meta-analysis
por: Cui, Wenpeng, et al.
Publicado: (2015) -
MG132 Ameliorates Kidney Lesions by Inhibiting the Degradation of Smad7 in Streptozotocin-Induced Diabetic Nephropathy
por: Gao, Chenlin, et al.
Publicado: (2014)